|
|
|
Insider
Information: |
Orford Keith |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
66,094 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,322 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
66,094 |
|
|
Total
Value |
$1,322 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-239.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Calithera Biosciences, Inc. |
CALA |
Director |
2021-11-11 |
66,094 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CALA |
Calithera Biosciences, In... |
Director |
|
2021-11-11 |
4 |
S |
$0.88 |
$42,407 |
D/D |
(48,190) |
66,094 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2021-11-10 |
4 |
S |
$0.86 |
$25,695 |
D/D |
(30,000) |
114,284 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2021-11-09 |
4 |
S |
$0.84 |
$43,520 |
D/D |
(51,810) |
144,284 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
Director |
|
2021-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
196,094 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
CHIEF MEDICAL OFFICER |
|
2021-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
166,094 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
CHIEF MEDICAL OFFICER |
|
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
76,094 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2020-12-16 |
4 |
AS |
$6.00 |
$14,682 |
D/D |
(2,447) |
11,094 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2020-02-20 |
4 |
AS |
$8.00 |
$24,168 |
D/D |
(3,021) |
8,541 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-12-23 |
4 |
AS |
$6.00 |
$18,126 |
D/D |
(3,021) |
11,562 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-06-17 |
4 |
AS |
$6.00 |
$2,502 |
D/D |
(417) |
12,083 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-05-22 |
4 |
AS |
$6.00 |
$2,496 |
D/D |
(416) |
10,000 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-04-15 |
4 |
AS |
$6.33 |
$2,633 |
D/D |
(416) |
10,416 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-03-15 |
4 |
AS |
$6.43 |
$2,681 |
D/D |
(417) |
10,832 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
Chief Medical Officer |
|
2019-03-11 |
4 |
AS |
$6.00 |
$9,390 |
D/D |
(1,565) |
11,249 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
SR. VP, CLINICAL DEVELOPMENT |
|
2018-10-15 |
4 |
AS |
$6.05 |
$1,894 |
D/D |
(313) |
10,314 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
SR. VP, CLINICAL DEVELOPMENT |
|
2018-10-11 |
4 |
AS |
$6.00 |
$7,512 |
D/D |
(1,252) |
10,627 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
SR. VP, CLINICAL DEVELOPMENT |
|
2017-07-17 |
4 |
AS |
$18.31 |
$38,823 |
D/D |
(2,120) |
6,879 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
SR. VP, CLINICAL DEVELOPMENTOf |
|
2016-05-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,120 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|